Photochemical and photobiological studies of tirapazamine (SR 4233) and related quinoxaline 1,4-Di-N-oxide analogues.
Tirapazamine, 3-amino-1,2,4-benzotriazine 1,4-di-N-oxide (TPZ; SR 4233), is currently undergoing phase II and III clinical trials as an antitumor agent. We have studied the photochemical properties of TPZ, and the related analogues 3-amino-2-quinoxalinecarbonitrile 1,4-di-N-oxide (TPZCN) and quinoxaline-1,4-di-N-oxide (quindoxin) with respect to their potential to photodamage DNA both oxidatively and reductively. We have found that TPZ, TPZCN, and quindoxin photosensitized the generation of singlet oxygen with quantum yields of 0.007, 0.19, and 0.02, respectively, in acetonitrile. Irradiation (lambda > 300 nm) of TPZ at pH 9.4 in the presence of a reducing agent, NADH, generated the corresponding nitroxide radical. At pH 7.4, photoirradiation of either TPZ or TPZCN in the presence of NADH in air saturated buffer gave the superoxide radical, which was trapped by 5,5-dimethyl-1-pyrroline N-oxide (DMPO). In the absence of a reducing agent, singlet oxygen generated from TPZCN oxidized DMPO to 5,5-dimethyl-2-oxopyrrolin-1-oxyl (DMPOX). No spin adducts were detected during photoirradiation of TPZ, NADH, and DMPO in nitrogen-saturated buffer. However, when DMSO was also present, the DMPO/(*)CH(3) adduct was observed, indicating the generation of the free hydroxyl radical. Both TPZ and TPZCN photooxidized reduced glutathione and azide to the glutathiyl and azidyl radicals, respectively. Under anaerobic conditions, NADH increased photoinduced strand breaks in pBR322 plasmid DNA caused by TPZ or TPZCN. For TPZ, the reactive species is probably the aforementioned nitroxide radical or the hydroxyl radical generated from its decomposition. In contrast, DNA damage by quindoxin was not affected by NADH, suggesting a different mechanism, possibly involving a photogenerated oxaziridine intermediate. These studies show that the photochemistry of TPZ, TPZCN, and quindoxin is complex and depends on the redox environment and whether oxygen is present.
Inbaraj
J Johnson
JJ
Laboratory of Pharmacology & Chemistry, NIEHS, Research Triangle Park, North Carolina 27709, USA.
Motten
Ann G
AG
Chignell
Colin F
CF
D000970:Antineoplastic Agents / Q000737:chemistry; D001386:Azides / Q000737:chemistry; D003198:Computer Simulation; D003497:Cyclic N-Oxides / Q000737:chemistry; D004249:DNA Damage / Q000528:radiation effects; D004578:Electron Spin Resonance Spectroscopy; D005609:Free Radicals / Q000737:chemistry / Q000145:classification; D005978:Glutathione / Q000737:chemistry; D009243:NAD / Q000737:chemistry; D010084:Oxidation-Reduction; D010782:Photolysis; D010957:Plasmids / Q000737:chemistry; D011810:Quinoxalines / Q000737:chemistry*; D011838:Radiation-Sensitizing Agents / Q000737:chemistry; D026082:Singlet Oxygen / Q000737:chemistry; D013053:Spectrophotometry / Q000379:methods; D013113:Spin Labels; D000077704:Tirapazamine; D014227:Triazines / Q000737:chemistry*
D000970:Antineoplastic Agents; D001386:Azides; D003497:Cyclic N-Oxides; D005609:Free Radicals; D011810:Quinoxalines; D011838:Radiation-Sensitizing Agents; D013113:Spin Labels; D014227:Triazines; D009243:NAD; D026082:Singlet Oxygen; D000077704:Tirapazamine; C017245:5,5-dimethyl-1-pyrroline-1-oxide; C003282:quindoxin; D005978:Glutathione